January 2003

Visibility of Neurofibromatosis 1 and Psychiatric Morbidity

Author Affiliations

Not Available


Copyright 2003 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2003

Arch Dermatol. 2003;139(1):103-104. doi:10.1001/archderm.139.1.103

Psychiatric comorbidities have been well documented in patients with neurofibromatosis 1 (NF1),13 and none of these psychological or psychiatric conditions are correlated with the severity of somatic symptoms.2,3 We recently published in the ARCHIVES that NF1 has a significant impact on quality of life through alteration of health and appearance.4 While conducting this quality-of-life study, we evaluated the impact of NF1 visibility and severity on psychiatric morbidity.